GLP-1 medication access online for Southaven, Mississippi

Company statements checked between September 10, 2026 and September 23, 2026: 2 covered companies — Gentle Health and GoodRx Care — advertise online GLP-1 medication access for patients in Mississippi, including Southaven. Confirm eligibility and total charges with the provider.

Browse online GLP-1 medication access programs advertised for patients in Southaven, Mississippi, with state-level access evidence.

· Updated

At a glance

GLP-1 medication access programs advertised for patients in Mississippi, alphabetical. Figures are the lowest structured monthly price on file; see the state guide for what is included.
CompanyOn this pageLowest listed monthly figureCheckedOfficial site
Gentle HealthCompounded oral semaglutide · Compounded injectable semaglutide · Compounded injectable tirzepatide$112/mo advertised monthly bundle, Compounded oral semaglutideOfficial site ↗
GoodRx CareWegovy pen · Wegovy HD · Wegovy tablet · Zepbound KwikPen$188/mo partial monthly subtotal, Wegovy tabletOfficial site ↗

Health context in Southaven

GLP-1 medication access programs are marketed for weight management and, for some products, type 2 diabetes. These Southaven figures give local context only. Among the 5 Mississippi cities in this research set, Southaven has the lowest estimate for diagnosed diabetes among adults (11.6%) and the lowest estimate for lack of health insurance among adults aged 18–64 (10.3%).

Southaven adults, age-adjusted estimates, with the city's rank among the 5 Mississippi cities in this research set. Ranks compare point estimates; where the 95% ranges overlap, the difference may not be meaningful.
MeasureSouthaven95% rangeAmong the 5 Mississippi cities in this research setYear
Obesity among adults37.1%30.6–43.8%fourth-highest2023
Diagnosed diabetes among adults11.6%10.1–13.3%lowest2023
High blood pressure among adults38.3%34.3–42.4%fourth-highest2023
Lack of health insurance among adults aged 18–6410.3%8.9–11.8%lowest2023
Routine checkup in the past year among adults80.4%77–83.5%fourth-highest2023

Source: CDC PLACES, 2025 release — model-based estimates from the Behavioral Risk Factor Surveillance System for Census place geography (total population 54,648); each measure is an estimate for adults. These describe the city's adults as a group; they do not indicate whether any person is eligible for, or should use, a treatment listed here.

This GLP-1 medication access page is the Southaven entry point to the Mississippi statewide online listing, not evidence of an office, pharmacy or clinician in Southaven. Each company below appears because its named products have their own Mississippi evidence; the heading does not extend coverage to every medicine in the category, and branded and compounded products are listed separately.

Use the Mississippi guide to compare the listed programs, their separate prices and their billing and cancellation terms before choosing which offer to ask a company about.

These are online services advertised for patients in Mississippi, listed alphabetically. They are not verified offices, pharmacies or clinicians located in Southaven, and a listing is not a prescription, appointment or coverage guarantee. Read the Mississippi GLP-1 medication access guide for product details, charges and limitations.

Selected providers

  • Gentle Health

    Gentle Health's separately priced compounded oral semaglutide, injectable semaglutide and injectable tirzepatide programs, if prescribed.

    Compounded oral semaglutide (oral): 2–4 mg/day — $112/mo · >4–8 mg/day — $189/mo · >8–12 mg/day — $258/mo — advertised monthly bundle; price checked

    Compounded injectable semaglutide (injection): 0.24–0.48 mg/wk — $135/mo · >0.48–1.2 mg/wk — $159/mo · >1.2–2.4 mg/wk — $199/mo — advertised monthly bundle; price checked

    Compounded injectable tirzepatide (injection): 2.5–5 mg/wk — $169/mo · >5–10 mg/wk — $219/mo · >10–15 mg/wk — $269/mo — advertised monthly bundle; price checked

    What's included, billing terms and sources

    Official provider website · Product and access details

    Medical Director: James Simmons, MD — company-reported; see profile for the source.

  • GoodRx Care

    GoodRx Care Direct, a cash-pay membership through which GoodRx advertises separately priced branded semaglutide and tirzepatide products.

    Wegovy pen (pen): 0.25 or 0.5 mg, first two fills — $238/mo · after the first two fills — $388/mo — partial monthly subtotal, not all-in, includes $39/mo membership; price checked

    Wegovy HD (pen): 7.2 mg — $438/mo — partial monthly subtotal, not all-in, includes $39/mo membership; price checked

    Wegovy tablet (oral tablet): 1.5 mg — $188/mo · 4 mg — $238/mo · higher doses, from — $338/mo — partial monthly subtotal, not all-in, includes $39/mo membership; price checked

    Zepbound KwikPen (pen): introductory KwikPen strength (page labels it 10 mg) — $338/mo — partial monthly subtotal, not all-in, includes $39/mo membership; price checked

    What's included, billing terms and sources

    Official provider website · Product and access details

Health center sites with Southaven addresses

If you want an in-person visit, HRSA-listed health center sites with Southaven postal addresses include:

  • DeSoto Community Health Center (Northeast Mississippi Health Care, Inc.) — 7535 Airways Blvd, Southaven, MS 38671 · 662-838-2163

From the HRSA health center directory (data retrieved ), listed alphabetically by organization and matched by postal address, not city boundaries; the list includes health center look-alikes, which do not receive Health Center Program funding. Not a ranking or recommendation. Call to confirm services, costs and whether a site can help with the programs on this page.

More listings

Other medications for Southaven: Semaglutide · Tirzepatide

GLP-1 medication access in other Mississippi cities: Biloxi · Gulfport · Hattiesburg · Jackson

Before requesting a prescription

Confirm the named product is offered where you will be during the visit, check eligibility, total charges and any supply commitment, and ask what happens if you need in-person care. This listing does not assess which treatment is right for you.